Subodh K Wadhwa, MD | |
1049 Summitt Dr, Middletown, OH 45042-3464 | |
(513) 423-1399 | |
(513) 423-4790 |
Full Name | Subodh K Wadhwa |
---|---|
Gender | Male |
Speciality | Neurology |
Experience | 51 Years |
Location | 1049 Summitt Dr, Middletown, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518938000 | NPI | - | NPPES |
0485603 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | 35.046467 (Ohio) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Atrium Medical Center | Franklin, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Premier Health Specialists Inc | 5597708594 | 394 |
News Archive
House Republicans are so bent on blocking any and all aspects of health care reform that they have passed a bill that would eliminate a farsighted program — the Prevention and Public Health Fund — intended to help states and communities prevent diseases. Eliminating the fund would save roughly $16 billion over the course of a decade. … The loss to states and local communities would be considerable.
Anyone who supports the plan to cover Americans who couldn't get health insurance has to hope the administration quickly gets it right. But you can't help but wonder: Where was all this frantic effort in the three-and-a-half years from the time Obama signed the health law to the day the exchanges opened on Oct. 1?
As the FDA warns consumers to stop using Hydroxycut products, a new editorial published in the May 2009 issue of The FASEB Journal shows that this FDA warning is not unique.
Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that it has filed an investigational new drug application with the US Food and Drug Administration to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia in pre-dialysis patients with chronic kidney disease.
› Verified 6 days ago
Entity Name | Premier Health Specialists Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1194958223 PECOS PAC ID: 5597708594 Enrollment ID: O20050610000010 |
News Archive
House Republicans are so bent on blocking any and all aspects of health care reform that they have passed a bill that would eliminate a farsighted program — the Prevention and Public Health Fund — intended to help states and communities prevent diseases. Eliminating the fund would save roughly $16 billion over the course of a decade. … The loss to states and local communities would be considerable.
Anyone who supports the plan to cover Americans who couldn't get health insurance has to hope the administration quickly gets it right. But you can't help but wonder: Where was all this frantic effort in the three-and-a-half years from the time Obama signed the health law to the day the exchanges opened on Oct. 1?
As the FDA warns consumers to stop using Hydroxycut products, a new editorial published in the May 2009 issue of The FASEB Journal shows that this FDA warning is not unique.
Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that it has filed an investigational new drug application with the US Food and Drug Administration to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia in pre-dialysis patients with chronic kidney disease.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Subodh K Wadhwa, MD 1049 Summitt Dr, Middletown, OH 45042-3464 Ph: (513) 423-1399 | Subodh K Wadhwa, MD 1049 Summitt Dr, Middletown, OH 45042-3464 Ph: (513) 423-1399 |
News Archive
House Republicans are so bent on blocking any and all aspects of health care reform that they have passed a bill that would eliminate a farsighted program — the Prevention and Public Health Fund — intended to help states and communities prevent diseases. Eliminating the fund would save roughly $16 billion over the course of a decade. … The loss to states and local communities would be considerable.
Anyone who supports the plan to cover Americans who couldn't get health insurance has to hope the administration quickly gets it right. But you can't help but wonder: Where was all this frantic effort in the three-and-a-half years from the time Obama signed the health law to the day the exchanges opened on Oct. 1?
As the FDA warns consumers to stop using Hydroxycut products, a new editorial published in the May 2009 issue of The FASEB Journal shows that this FDA warning is not unique.
Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that it has filed an investigational new drug application with the US Food and Drug Administration to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia in pre-dialysis patients with chronic kidney disease.
› Verified 6 days ago
Dr. Marvin Baula, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4464 S Dixie Hwy, Middletown, OH 45005 Phone: 513-649-8008 | |
Andrea C Ribier, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4464 S Dixie Hwy, Middletown, OH 45005 Phone: 513-649-8008 Fax: 513-649-8004 | |
Judith Ann Freeland, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4464 S Dixie Hwy, Middletown, OH 45005 Phone: 513-649-8008 Fax: 513-649-8004 | |
Dr. Rachel Michelle Cash, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4464 S Dixie Hwy, Department Of Psychiatry, Middletown, OH 45005 Phone: 513-649-8008 Fax: 513-649-8004 | |
Rokeya Tasnin, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4464 S Dixie Hwy, Middletown, OH 45005 Phone: 513-649-8008 Fax: 513-649-8004 | |
Percy David Mitchell Jr., MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1054 Summit Dr, Middletown, OH 45042 Phone: 513-727-1987 Fax: 513-727-0918 | |
Irfan Dahar, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6730 Roosevelt Ave Ste 201, Middletown, OH 45005 Phone: 513-279-0857 |